门冬氨酸钾镁治疗急性心肌梗死心律失常的临床效果及心电图特征分析

Analysis of Clinical Effect of Nmda Potassium Magnesium for Treatment of Acute Myocardial Infarction Arrhythmia and Characteristics of Electrocardiogram(ecg)

目的:探究门冬氨酸钾镁治疗急性心肌梗死心律失常的临床效果及心电图特征。方法:选取72例急性心肌梗死合并心律失常患者进行本次试验研究,分析患者心电图特征,将患者分为研究组和对照组,对照组患者予以常规治疗,研究组在对照组治疗基础上联合门冬氨酸钾镁治疗,对比两组患者治疗总有效率及不良反应情况。结果:急性心肌梗死患者中室性心律失常多见,其中室性早搏49例,阵发性室性心动过速6例,心室颤动4例,其他13例(包括窦性心动过速5例,房性早搏2例,心房纤颤3例,房室传导阻滞3例),心电图显示ST段抬高患者37例,病死率为2.70%(1/37),非ST段抬高患者35例,病死率14.29%(5/35),两者病死率对比,P<0.05,差异具有统计学意义;治疗后两组患者总有效率对比,研究组明显高于对照组,差异具有统计学意义(P<0.05);两组总不良反应率相近,对比无差异(P>0.05)。结论:急性心肌梗死患者中室性心律失常最为多见,采取门冬氨酸钾镁治疗后临床效果显著,且不良反应少,具有较高临床应用与推广价值。

Objective To explore the nmda potassium magnesium for treatment of acute myocardial infarction, arrhythmia and electrocardiogram （ecg） characteristics. Methods： Select 72 cases of acute myocardial infarction merger arrhythmia patients for the study, analysis of electrocardiogram （ecg） in patients with characteristics,divided the patients into the group and the control group, control group patients give regular treatment , the team in the control group treatment based on joint nmda potassium magnesium treatment, compare the total effective rate of two groups of patients and adverse reactions. Results： Acute myocardial infarction in patients with ventricular arrhythmia, ventricular premature beat 49 cases, 6 cases of paroxysmal ventricular tachycardia and ventricular fibrillation in 4 cases, and other 13 cases （including 5 cases with sinus tachycardia,room sex premature beat in 2 cases,3 cases of atrial fibrillation （af） , atrioventricular block （3 cases）,37 patients with ST segment elevation on the electrocardiogram, and the case fatality rate was 2.70 % （1/37）, 35 patients with non ST segment elevation, the case fatality rate 14.29% （5/35） ,the case fatality rate,P 〈 0.05, the difference is statistically significant; Total effective contrast, two groups of patients after treatment group is significantly higher than the control group, the difference is statistically significant （P〈 0.05）; Two groups of total adverse reaction rate, compared with no difference （P 〉0.05）. Conclusion： The most acute myocardial infarction in patients with ventricular arrhythmia more see, taken after nmda potassium magnesium therapy clinical effect is remarkable, and less adverse reaction,has high clinical application and popularization value.